Cargando…
Polymorphisms in CLDN1 are associated with age and differentiation of triple-negative breast cancer patients
Purpose: Triple-negative breast cancer (TNBC) is a highly heterogeneous disease. It is very important to explore novel biomarkers to better clarify the characteristics of TNBC. It has been reported that polymorphisms in claudin 1 (CLDN1) are associated with risk of several cancers. But till now, the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481238/ https://www.ncbi.nlm.nih.gov/pubmed/30910845 http://dx.doi.org/10.1042/BSR20181952 |